Literature DB >> 28916369

Antiangiogenesis to curb urothelial cancer.

Joaquim Bellmunt1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28916369     DOI： 10.1016/S0140-6736(17)32388-7

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  2 in total

Review 1.  Emerging biomarkers and targeted therapies in urothelial carcinoma.

Authors:  Prateek Mendiratta; Petros Grivas
Journal:  Ann Transl Med       Date:  2018-06

2.  A novel risk score model based on five angiogenesis-related long non-coding RNAs for bladder urothelial carcinoma.

Authors:  Xinyuan Li; Chunlin Zhang; Xiang Peng; Yang Li; Guo Chen; Xin Gou; Xiang Zhou; Chao Ma
Journal:  Cancer Cell Int       Date:  2022-04-19       Impact factor: 6.429
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.